CD8A and neoplasm: Professional antigen-presenting cells (APCs), like dendritic cells (DCs), can display exogenous tumor antigens on major histocompatibility complex class I (MHC I) or II molecules, priming CD8+ T cells (cytotoxic T lymphocytes, CTLs) or CD4+ T cells (T helper cells, Th), respectively.